Global Markets and Technologies for Cell and Tissue Analysis

Apr 2023| BIO068D| BCC Publishing
Sample Report

Report Highlights

The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.

Report Includes

  • 30 data tables and 20 additional tables
  • A detailed overview and an up-to-date analysis of the global market for cell and tissue analysis (CTA) products and technologies
  • Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Discussion of the industry growth driving factors and restraints that will shape the market for CTA products as the basis for projecting demand over the next few years (2022-2027)
  • Estimation of the actual market size and revenue forecast for global cell and tissue analysis products market in USD millions, and corresponding market share analysis by type, application, end-user, and region
  • Review of the commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
  • Identification of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
  • Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
  • Information about patents and patent applications for cell and tissue analysis products and technologies by each major category
  • Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
  • Detailed company profiles of the leading industry players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Healthcare, Merck KGaA, PerkinElmer and Thermo Fisher Scientific Inc.

Report Scope

This report focuses on the global market of cell and tissue analysis (CTA) products and provides an updated review, including basic design and applications in various arenas of biomedical and life science research. The report deals with CTA products covering the total market, which includes three main areas of applications. These are biospecimen preparation techniques, cell separation products, and cell and tissue characterization products. These categories are further subdivided into various types. The report also covers the market for cell and tissue analysis products by end user. The end users of cell and tissue analysis products are categorized as research and academics, biopharmaceuticals, and healthcare and clinical. Excluded from this report are immunoassays.

BCC Research analyzed each market and its application, regulatory environment, new products and advancements, patent analysis, market projections, and market shares. The current report provides a detailed analysis of the market’s drivers, challenges, opportunities, and impact of COVID-19. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments.

Frequently Asked Questions (FAQs)

• The global cell and tissue analysis market is estimated to be $16.7 billion in 2021 and is expected to increase to nearly $28.9 billion by 2027, growing at a CAGR of 9.6% during the forecast period.
• The key factors contributing to the growth of the market include increasing investments and funding for research and development, increasing prevalence of chronic diseases, and rising demand for personalised medicines, increasing demand for single-cell analysis and technological advancements are driving the cell and tissue analysis market.
• In this report, the market is segmented based on technology type, end-user, and region.
• Cell and Tissue Characterization segment will dominate the market by the end of 2027.
• North America holds the highest share in the market.
Major players in the market are Thermo Fisher, Danaher, Becton & Dickinson, Agilent Technologies and Illumina.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $16.7 billion
Market size forecast $28.9 billion
Growth rate CAGR of 9.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered technology type, end-user, and region
Regions covered North America, Europe, Emerging markets
Key Market Drivers
  • Development of High-End Technology
  • Increasing Demand for Single-Cell Analysis
  • Increasing Prevalence of Diseases
  • Increasing Demand for Personalized Medicine
  • Increasing Investments and Spending for Research and Development
  • Difficulty Obtaining Regulatory Approval
  • High Cost of Instruments
  • Lack of Awareness of the Science
  • Lack of Skilled Professionals
Companies studied ABCAM PLC , ABNOVA CORP. , AGILENT TECHNOLOGIES INC. , ARRAYIT CORP. , BECTON, DICKINSON AND COMPANY , BIO-RAD LABORATORIES, INC. , BIO-TECHNE CORP. , CARL ZEISS , CELL SIGNALING TECHNOLOGY INC. , DANAHER CORP. , FUJIFILM CELLULAR DYNAMICS INC. (FCDI) , GE HEALTHCARE , F. HOFFMANN-LA ROCHE AG , ILLUMINA INC. , LUMINEX CORP. , MERCK KGAA , MILTENYI BIOTEC , PERKINELMER INC. , SARTORIUS AG , STEMCELL TECHNOLOGIES , SYSMEX CORP. , THERMO FISHER SCIENTIFIC INC. , WORTHINGTON BIOCHEMICAL CORP.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Global Markets and Technologies for Cell and Tissue Analysis151 $5,500 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background12$437Free
Chapter- 4: Market Dynamics9$328Free
Chapter- 5: Emerging Technologies2$73Free
Chapter- 6: Market Breakdown by Technology22$801Free
Chapter- 7: Market Breakdown by End User17$619Free
Chapter- 8: Market Breakdown by Region4$146Free
Chapter- 9: Regulatory Aspects6$219Free
Chapter- 10: Patent Analysis4$146Free
Chapter- 11: Competitive Landscape17$619Free
Chapter- 12: Company Profiles49$1,785Free
Published - Mar-2016| Analyst - Shalini Shahani Dewan| Code - BIO068C

Report Highlights

The global cell and tissue analysis products market reached $10.8 billion in 2015 and should reach nearly $12.5 billion by 2020, with a compound annual growth rate (CAGR) of 2.8% through 2020.

Report Includes

  • An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms.
  • Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players.
  • Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products.
  • Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Published - Jan-2013| Analyst - Shalini Shahani Dewan| Code - BIO068B

Report Highlights

The global cell and tissue analysis market was valued at $6.9 billion in 2011 and should reach $7.1 billion in 2012. Total market value is expected to reach $9.6 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 6.2%. 

Report Includes

  • An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years.
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms.
  • Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players.
  • Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products.
  • Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Published - Sep-2009| Analyst - Willem Westra| Code - BIO068A

Report Highlights

  • Overall sales in the global market of cell and tissue analysis products were worth $2.6 billion in 2008, which increased to an estimated $2.8 billion in 2009. By 2014, it is projected to increase to $4.5 billion, for a 5-year CAGR of 10.1%.
  • The largest segment of the market, cell and tissue characterization products was valued at $1.2 billion in 2008; this is expected to increase to $1.3 billion in 2009, and is projected to reach $2.2 billion in 2014, for a 5-year CAGR of 10.8%.
  • Sales in the cell separation products segment amounted to $1.2 billion in 2008, increased to an estimated $1.3 billion in 2009, and is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 9.8%.
Global Markets and Technologies for Cell and Tissue Analysis

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS